Hypermetaphase and interphase fluorescence in situ hybridisation for monitoring of remission status in Philadelphia chromosome positive chronic myeloid leukaemia.

International journal of oncology, 2000 - spandidos-publications.com
Interferon (IFN) alone or in combination with cytostatic drugs, can induce major and durable
cytogenetic remissions in chronic myelogenous leukaemia (CML) patients. Hypermetaphase …
被引用次数：8 相关文章

Hypermetaphase and interphase fluorescence in situ hybridisation for monitoring of remission status in Philadelphia chromosome positive chronic myeloid leukaemia.

HC Duba, W Hilbe, A Mehringer… - International …, 2000 - spandidos-publications.com
Interferon (IFN) alone or in combination with cytostatic drugs, can induce major and durable
cytogenetic remissions in chronic myelogenous leukaemia (CML) patients. Hypermetaphase …

[引用][C] Hypermetaphase and interphase fluorescence in situ hybridisation for monitoring of remission status in Philadelphia chromosome positive chronic myeloid …

HC DUBA, W HILBE, A MEHRINGER… - … journal of oncology, 2000 - pascal-francis.inist.fr
Hypermetaphase and interphase fluorescence in situ hybridisation for monitoring of remission
status in Philadelphia chromosome positive chronic myeloid leukaemia CNRS Inist Pascal-Francis …

Hypermetaphase and interphase fluorescence in situ hybridisation for monitoring of remission status in Philadelphia chromosome positive chronic myeloid leukaemia.

HC Duba, W Hilbe, A Mehringer, M Erdel… - … Journal of Oncology, 2000 - ingentaconnect.com
Interferon (IFN) alone or in combination with cytostatic drugs, can induce major and durable
cytogenetic remissions in chronic myelogenous leukaemia (CML) patients. Hypermetaphase …

Hypermetaphase and interphase fluorescence in situ hybridisation for monitoring of remission status in Philadelphia chromosome positive chronic myeloid leukaemia.

HC Duba, W Hilbe, A Mehringer, M Erdel… - … Journal of Oncology, 2000 - europepmc.org
Interferon (IFN) alone or in combination with cytostatic drugs, can induce major and durable
cytogenetic remissions in chronic myelogenous leukaemia (CML) patients. Hypermetaphase …

Hypermetaphase and interphase fluorescence in situ hybridisation for monitoring of remission status in Philadelphia chromosome positive chronic myeloid leukaemia

HC Duba, W Hilbe, A Mehringer… - … journal of oncology, 2000 - pubmed.ncbi.nlm.nih.gov
Interferon (IFN) alone or in combination with cytostatic drugs, can induce major and durable
cytogenetic remissions in chronic myelogenous leukaemia (CML) patients. Hypermetaphase …

[引用][C] Hypermetaphase and interphase fluorescence in situ hybridisation for monitoring of remission status in Philadelphia chromosome positive chronic myeloid …

HC DUBA, W HILBE… - International …, 2000 - Editorial Academy of the …